nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—GABBR1—hair follicle—melanoma	0.00937	0.328	CbGeAlD
Baclofen—SLC22A8—optic choroid—melanoma	0.00918	0.321	CbGeAlD
Baclofen—Chlorpropamide—SLC15A2—melanoma	0.00547	0.299	CrCbGaD
Baclofen—GABBR2—head—melanoma	0.00526	0.184	CbGeAlD
Baclofen—Ibuprofen—BCL2—melanoma	0.00333	0.182	CrCbGaD
Baclofen—Ibuprofen—CXCL8—melanoma	0.00267	0.146	CrCbGaD
Baclofen—GABBR1—lymph node—melanoma	0.00186	0.0651	CbGeAlD
Baclofen—SLC22A8—eye—melanoma	0.00185	0.0647	CbGeAlD
Baclofen—Ibuprofen—PPARG—melanoma	0.00184	0.101	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—melanoma	0.00174	0.0952	CrCbGaD
Baclofen—Hepatobiliary disease—Temozolomide—melanoma	0.00124	0.00249	CcSEcCtD
Baclofen—Alopecia—Bleomycin—melanoma	0.00124	0.00248	CcSEcCtD
Baclofen—Hypoaesthesia—Carmustine—melanoma	0.00122	0.00243	CcSEcCtD
Baclofen—Hallucination—Carmustine—melanoma	0.00122	0.00243	CcSEcCtD
Baclofen—Flushing—Dactinomycin—melanoma	0.00121	0.00243	CcSEcCtD
Baclofen—Oedema peripheral—Carmustine—melanoma	0.0012	0.00241	CcSEcCtD
Baclofen—Connective tissue disorder—Carmustine—melanoma	0.0012	0.0024	CcSEcCtD
Baclofen—Visual disturbance—Docetaxel—melanoma	0.0012	0.0024	CcSEcCtD
Baclofen—Asthenia—Vemurafenib—melanoma	0.00118	0.00236	CcSEcCtD
Baclofen—Visual impairment—Carmustine—melanoma	0.00118	0.00236	CcSEcCtD
Baclofen—Hypoaesthesia—Temozolomide—melanoma	0.00117	0.00235	CcSEcCtD
Baclofen—Hallucination—Temozolomide—melanoma	0.00117	0.00235	CcSEcCtD
Baclofen—Chills—Dactinomycin—melanoma	0.00117	0.00234	CcSEcCtD
Baclofen—Urinary tract disorder—Temozolomide—melanoma	0.00117	0.00233	CcSEcCtD
Baclofen—Oedema peripheral—Temozolomide—melanoma	0.00116	0.00233	CcSEcCtD
Baclofen—Pruritus—Vemurafenib—melanoma	0.00116	0.00232	CcSEcCtD
Baclofen—Connective tissue disorder—Temozolomide—melanoma	0.00116	0.00232	CcSEcCtD
Baclofen—Lethargy—Docetaxel—melanoma	0.00116	0.00232	CcSEcCtD
Baclofen—Urethral disorder—Temozolomide—melanoma	0.00116	0.00232	CcSEcCtD
Baclofen—Alopecia—Dactinomycin—melanoma	0.00115	0.00231	CcSEcCtD
Baclofen—Eye disorder—Carmustine—melanoma	0.00114	0.00229	CcSEcCtD
Baclofen—Visual impairment—Temozolomide—melanoma	0.00114	0.00228	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00113	0.00227	CcSEcCtD
Baclofen—Flushing—Carmustine—melanoma	0.00113	0.00227	CcSEcCtD
Baclofen—Ill-defined disorder—Bleomycin—melanoma	0.00113	0.00226	CcSEcCtD
Baclofen—Anaemia—Bleomycin—melanoma	0.00113	0.00225	CcSEcCtD
Baclofen—Chlorpropamide—ABCB1—melanoma	0.00112	0.0614	CrCbGaD
Baclofen—Diarrhoea—Vemurafenib—melanoma	0.00112	0.00225	CcSEcCtD
Baclofen—Eye disorder—Temozolomide—melanoma	0.0011	0.00221	CcSEcCtD
Baclofen—Tinnitus—Temozolomide—melanoma	0.0011	0.0022	CcSEcCtD
Baclofen—Malaise—Bleomycin—melanoma	0.0011	0.0022	CcSEcCtD
Baclofen—Cardiac disorder—Temozolomide—melanoma	0.0011	0.00219	CcSEcCtD
Baclofen—Flushing—Temozolomide—melanoma	0.0011	0.00219	CcSEcCtD
Baclofen—Arrhythmia—Carmustine—melanoma	0.00109	0.00218	CcSEcCtD
Baclofen—Dizziness—Vemurafenib—melanoma	0.00109	0.00217	CcSEcCtD
Baclofen—Alopecia—Carmustine—melanoma	0.00108	0.00216	CcSEcCtD
Baclofen—Angiopathy—Temozolomide—melanoma	0.00107	0.00214	CcSEcCtD
Baclofen—Mental disorder—Carmustine—melanoma	0.00107	0.00214	CcSEcCtD
Baclofen—Ataxia—Docetaxel—melanoma	0.00107	0.00214	CcSEcCtD
Baclofen—Mediastinal disorder—Temozolomide—melanoma	0.00106	0.00213	CcSEcCtD
Baclofen—Malnutrition—Carmustine—melanoma	0.00106	0.00213	CcSEcCtD
Baclofen—Chills—Temozolomide—melanoma	0.00106	0.00212	CcSEcCtD
Baclofen—Dehydration—Docetaxel—melanoma	0.00106	0.00211	CcSEcCtD
Baclofen—Ill-defined disorder—Dactinomycin—melanoma	0.00105	0.00211	CcSEcCtD
Baclofen—Anaemia—Dactinomycin—melanoma	0.00105	0.0021	CcSEcCtD
Baclofen—SLC22A8—head—melanoma	0.00105	0.0367	CbGeAlD
Baclofen—Vomiting—Vemurafenib—melanoma	0.00104	0.00209	CcSEcCtD
Baclofen—Alopecia—Temozolomide—melanoma	0.00104	0.00209	CcSEcCtD
Baclofen—Chest pain—Bleomycin—melanoma	0.00104	0.00208	CcSEcCtD
Baclofen—Myalgia—Bleomycin—melanoma	0.00104	0.00208	CcSEcCtD
Baclofen—Orthostatic hypotension—Docetaxel—melanoma	0.00104	0.00208	CcSEcCtD
Baclofen—Rash—Vemurafenib—melanoma	0.00103	0.00207	CcSEcCtD
Baclofen—Mental disorder—Temozolomide—melanoma	0.00103	0.00207	CcSEcCtD
Baclofen—Dermatitis—Vemurafenib—melanoma	0.00103	0.00207	CcSEcCtD
Baclofen—Back pain—Carmustine—melanoma	0.00103	0.00206	CcSEcCtD
Baclofen—Headache—Vemurafenib—melanoma	0.00103	0.00206	CcSEcCtD
Baclofen—Malnutrition—Temozolomide—melanoma	0.00103	0.00206	CcSEcCtD
Baclofen—Breast disorder—Docetaxel—melanoma	0.00103	0.00205	CcSEcCtD
Baclofen—Discomfort—Bleomycin—melanoma	0.00102	0.00205	CcSEcCtD
Baclofen—Malaise—Dactinomycin—melanoma	0.00102	0.00205	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00102	0.00205	CcSEcCtD
Baclofen—Dysgeusia—Temozolomide—melanoma	0.00101	0.00201	CcSEcCtD
Baclofen—Confusional state—Bleomycin—melanoma	0.001	0.00201	CcSEcCtD
Baclofen—Vision blurred—Carmustine—melanoma	0.001	0.00201	CcSEcCtD
Baclofen—Tremor—Carmustine—melanoma	0.000996	0.00199	CcSEcCtD
Baclofen—Oedema—Bleomycin—melanoma	0.000994	0.00199	CcSEcCtD
Baclofen—Back pain—Temozolomide—melanoma	0.000994	0.00199	CcSEcCtD
Baclofen—Infection—Bleomycin—melanoma	0.000988	0.00198	CcSEcCtD
Baclofen—Anaemia—Carmustine—melanoma	0.000983	0.00197	CcSEcCtD
Baclofen—Dysphagia—Docetaxel—melanoma	0.000981	0.00196	CcSEcCtD
Baclofen—Agitation—Carmustine—melanoma	0.000977	0.00196	CcSEcCtD
Baclofen—Nausea—Vemurafenib—melanoma	0.000975	0.00195	CcSEcCtD
Baclofen—Vision blurred—Temozolomide—melanoma	0.000968	0.00194	CcSEcCtD
Baclofen—Myalgia—Dactinomycin—melanoma	0.000967	0.00194	CcSEcCtD
Baclofen—Tremor—Temozolomide—melanoma	0.000963	0.00193	CcSEcCtD
Baclofen—Discomfort—Dactinomycin—melanoma	0.000956	0.00191	CcSEcCtD
Baclofen—Ill-defined disorder—Temozolomide—melanoma	0.000953	0.00191	CcSEcCtD
Baclofen—Anaemia—Temozolomide—melanoma	0.00095	0.0019	CcSEcCtD
Baclofen—Anorexia—Bleomycin—melanoma	0.000948	0.0019	CcSEcCtD
Baclofen—Agitation—Temozolomide—melanoma	0.000944	0.00189	CcSEcCtD
Baclofen—Hypotension—Bleomycin—melanoma	0.000929	0.00186	CcSEcCtD
Baclofen—Oedema—Dactinomycin—melanoma	0.000927	0.00186	CcSEcCtD
Baclofen—Malaise—Temozolomide—melanoma	0.000927	0.00186	CcSEcCtD
Baclofen—Vertigo—Temozolomide—melanoma	0.000923	0.00185	CcSEcCtD
Baclofen—Convulsion—Carmustine—melanoma	0.000921	0.00184	CcSEcCtD
Baclofen—Infection—Dactinomycin—melanoma	0.000921	0.00184	CcSEcCtD
Baclofen—Hypertension—Carmustine—melanoma	0.000918	0.00184	CcSEcCtD
Baclofen—Palpitations—Temozolomide—melanoma	0.000908	0.00182	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Bleomycin—melanoma	0.000906	0.00181	CcSEcCtD
Baclofen—Chest pain—Carmustine—melanoma	0.000905	0.00181	CcSEcCtD
Baclofen—Myalgia—Carmustine—melanoma	0.000905	0.00181	CcSEcCtD
Baclofen—Anxiety—Carmustine—melanoma	0.000902	0.00181	CcSEcCtD
Baclofen—Paraesthesia—Bleomycin—melanoma	0.000893	0.00179	CcSEcCtD
Baclofen—Weight increased—Docetaxel—melanoma	0.000893	0.00179	CcSEcCtD
Baclofen—Convulsion—Temozolomide—melanoma	0.00089	0.00178	CcSEcCtD
Baclofen—Weight decreased—Docetaxel—melanoma	0.000887	0.00178	CcSEcCtD
Baclofen—Hypertension—Temozolomide—melanoma	0.000887	0.00178	CcSEcCtD
Baclofen—Dyspnoea—Bleomycin—melanoma	0.000886	0.00177	CcSEcCtD
Baclofen—Anorexia—Dactinomycin—melanoma	0.000884	0.00177	CcSEcCtD
Baclofen—Pneumonia—Docetaxel—melanoma	0.00088	0.00176	CcSEcCtD
Baclofen—Confusional state—Carmustine—melanoma	0.000875	0.00175	CcSEcCtD
Baclofen—Myalgia—Temozolomide—melanoma	0.000875	0.00175	CcSEcCtD
Baclofen—Anxiety—Temozolomide—melanoma	0.000872	0.00175	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000869	0.00174	CcSEcCtD
Baclofen—Oedema—Carmustine—melanoma	0.000868	0.00174	CcSEcCtD
Baclofen—Discomfort—Temozolomide—melanoma	0.000864	0.00173	CcSEcCtD
Baclofen—Decreased appetite—Bleomycin—melanoma	0.000864	0.00173	CcSEcCtD
Baclofen—Infection—Carmustine—melanoma	0.000862	0.00173	CcSEcCtD
Baclofen—Renal failure—Docetaxel—melanoma	0.00086	0.00172	CcSEcCtD
Baclofen—Dry mouth—Temozolomide—melanoma	0.000856	0.00171	CcSEcCtD
Baclofen—Pain—Bleomycin—melanoma	0.00085	0.0017	CcSEcCtD
Baclofen—Tachycardia—Carmustine—melanoma	0.000847	0.0017	CcSEcCtD
Baclofen—Confusional state—Temozolomide—melanoma	0.000846	0.00169	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000845	0.00169	CcSEcCtD
Baclofen—Oedema—Temozolomide—melanoma	0.000839	0.00168	CcSEcCtD
Baclofen—Infection—Temozolomide—melanoma	0.000833	0.00167	CcSEcCtD
Baclofen—Anorexia—Carmustine—melanoma	0.000827	0.00166	CcSEcCtD
Baclofen—Hepatobiliary disease—Docetaxel—melanoma	0.000827	0.00166	CcSEcCtD
Baclofen—Nervous system disorder—Temozolomide—melanoma	0.000822	0.00165	CcSEcCtD
Baclofen—Feeling abnormal—Bleomycin—melanoma	0.000819	0.00164	CcSEcCtD
Baclofen—Skin disorder—Temozolomide—melanoma	0.000815	0.00163	CcSEcCtD
Baclofen—Hypotension—Carmustine—melanoma	0.000811	0.00162	CcSEcCtD
Baclofen—Hyperhidrosis—Temozolomide—melanoma	0.000811	0.00162	CcSEcCtD
Baclofen—Decreased appetite—Dactinomycin—melanoma	0.000806	0.00161	CcSEcCtD
Baclofen—Fatigue—Dactinomycin—melanoma	0.000799	0.0016	CcSEcCtD
Baclofen—Anorexia—Temozolomide—melanoma	0.000799	0.0016	CcSEcCtD
Baclofen—Pain—Dactinomycin—melanoma	0.000793	0.00159	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Carmustine—melanoma	0.000791	0.00158	CcSEcCtD
Baclofen—Urticaria—Bleomycin—melanoma	0.00079	0.00158	CcSEcCtD
Baclofen—Rhinitis—Docetaxel—melanoma	0.000787	0.00158	CcSEcCtD
Baclofen—Body temperature increased—Bleomycin—melanoma	0.000786	0.00157	CcSEcCtD
Baclofen—Insomnia—Carmustine—melanoma	0.000785	0.00157	CcSEcCtD
Baclofen—Hypoaesthesia—Docetaxel—melanoma	0.000781	0.00156	CcSEcCtD
Baclofen—Paraesthesia—Carmustine—melanoma	0.000779	0.00156	CcSEcCtD
Baclofen—Ibuprofen—PTGS2—melanoma	0.000778	0.0425	CrCbGaD
Baclofen—Urinary tract disorder—Docetaxel—melanoma	0.000775	0.00155	CcSEcCtD
Baclofen—Dyspnoea—Carmustine—melanoma	0.000774	0.00155	CcSEcCtD
Baclofen—Oedema peripheral—Docetaxel—melanoma	0.000773	0.00155	CcSEcCtD
Baclofen—Somnolence—Carmustine—melanoma	0.000772	0.00154	CcSEcCtD
Baclofen—Connective tissue disorder—Docetaxel—melanoma	0.000771	0.00154	CcSEcCtD
Baclofen—Urethral disorder—Docetaxel—melanoma	0.00077	0.00154	CcSEcCtD
Baclofen—Feeling abnormal—Dactinomycin—melanoma	0.000764	0.00153	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Temozolomide—melanoma	0.000764	0.00153	CcSEcCtD
Baclofen—Insomnia—Temozolomide—melanoma	0.000759	0.00152	CcSEcCtD
Baclofen—Gastrointestinal pain—Dactinomycin—melanoma	0.000758	0.00152	CcSEcCtD
Baclofen—Visual impairment—Docetaxel—melanoma	0.000757	0.00151	CcSEcCtD
Baclofen—Decreased appetite—Carmustine—melanoma	0.000754	0.00151	CcSEcCtD
Baclofen—Paraesthesia—Temozolomide—melanoma	0.000753	0.00151	CcSEcCtD
Baclofen—Gastrointestinal disorder—Carmustine—melanoma	0.000749	0.0015	CcSEcCtD
Baclofen—Dyspnoea—Temozolomide—melanoma	0.000748	0.0015	CcSEcCtD
Baclofen—Somnolence—Temozolomide—melanoma	0.000746	0.00149	CcSEcCtD
Baclofen—Pain—Carmustine—melanoma	0.000742	0.00149	CcSEcCtD
Baclofen—Constipation—Carmustine—melanoma	0.000742	0.00149	CcSEcCtD
Baclofen—Dyspepsia—Temozolomide—melanoma	0.000738	0.00148	CcSEcCtD
Baclofen—Eye disorder—Docetaxel—melanoma	0.000734	0.00147	CcSEcCtD
Baclofen—Body temperature increased—Dactinomycin—melanoma	0.000733	0.00147	CcSEcCtD
Baclofen—Abdominal pain—Dactinomycin—melanoma	0.000733	0.00147	CcSEcCtD
Baclofen—Decreased appetite—Temozolomide—melanoma	0.000729	0.00146	CcSEcCtD
Baclofen—Flushing—Docetaxel—melanoma	0.000729	0.00146	CcSEcCtD
Baclofen—Cardiac disorder—Docetaxel—melanoma	0.000729	0.00146	CcSEcCtD
Baclofen—Gastrointestinal disorder—Temozolomide—melanoma	0.000724	0.00145	CcSEcCtD
Baclofen—Fatigue—Temozolomide—melanoma	0.000723	0.00145	CcSEcCtD
Baclofen—Pain—Temozolomide—melanoma	0.000717	0.00144	CcSEcCtD
Baclofen—Constipation—Temozolomide—melanoma	0.000717	0.00144	CcSEcCtD
Baclofen—Feeling abnormal—Carmustine—melanoma	0.000715	0.00143	CcSEcCtD
Baclofen—Asthenia—Bleomycin—melanoma	0.000713	0.00143	CcSEcCtD
Baclofen—Angiopathy—Docetaxel—melanoma	0.000712	0.00143	CcSEcCtD
Baclofen—Gastrointestinal pain—Carmustine—melanoma	0.00071	0.00142	CcSEcCtD
Baclofen—Mediastinal disorder—Docetaxel—melanoma	0.000708	0.00142	CcSEcCtD
Baclofen—Chills—Docetaxel—melanoma	0.000704	0.00141	CcSEcCtD
Baclofen—Pruritus—Bleomycin—melanoma	0.000703	0.00141	CcSEcCtD
Baclofen—Arrhythmia—Docetaxel—melanoma	0.000701	0.0014	CcSEcCtD
Baclofen—Alopecia—Docetaxel—melanoma	0.000694	0.00139	CcSEcCtD
Baclofen—Ibuprofen—ALB—melanoma	0.000693	0.0379	CrCbGaD
Baclofen—Feeling abnormal—Temozolomide—melanoma	0.000691	0.00138	CcSEcCtD
Baclofen—Mental disorder—Docetaxel—melanoma	0.000688	0.00138	CcSEcCtD
Baclofen—Abdominal pain—Carmustine—melanoma	0.000686	0.00137	CcSEcCtD
Baclofen—Body temperature increased—Carmustine—melanoma	0.000686	0.00137	CcSEcCtD
Baclofen—Gastrointestinal pain—Temozolomide—melanoma	0.000686	0.00137	CcSEcCtD
Baclofen—Malnutrition—Docetaxel—melanoma	0.000683	0.00137	CcSEcCtD
Baclofen—Dysgeusia—Docetaxel—melanoma	0.000669	0.00134	CcSEcCtD
Baclofen—Urticaria—Temozolomide—melanoma	0.000666	0.00133	CcSEcCtD
Baclofen—Asthenia—Dactinomycin—melanoma	0.000665	0.00133	CcSEcCtD
Baclofen—Abdominal pain—Temozolomide—melanoma	0.000663	0.00133	CcSEcCtD
Baclofen—Body temperature increased—Temozolomide—melanoma	0.000663	0.00133	CcSEcCtD
Baclofen—Ibuprofen—ABCB1—melanoma	0.000662	0.0361	CrCbGaD
Baclofen—Back pain—Docetaxel—melanoma	0.000661	0.00132	CcSEcCtD
Baclofen—Diarrhoea—Dactinomycin—melanoma	0.000634	0.00127	CcSEcCtD
Baclofen—Vomiting—Bleomycin—melanoma	0.000632	0.00127	CcSEcCtD
Baclofen—Anaemia—Docetaxel—melanoma	0.000632	0.00126	CcSEcCtD
Baclofen—Rash—Bleomycin—melanoma	0.000627	0.00126	CcSEcCtD
Baclofen—Dermatitis—Bleomycin—melanoma	0.000626	0.00125	CcSEcCtD
Baclofen—Asthenia—Carmustine—melanoma	0.000623	0.00125	CcSEcCtD
Baclofen—Syncope—Docetaxel—melanoma	0.000613	0.00123	CcSEcCtD
Baclofen—Palpitations—Docetaxel—melanoma	0.000604	0.00121	CcSEcCtD
Baclofen—Asthenia—Temozolomide—melanoma	0.000602	0.0012	CcSEcCtD
Baclofen—Loss of consciousness—Docetaxel—melanoma	0.000601	0.0012	CcSEcCtD
Baclofen—Diarrhoea—Carmustine—melanoma	0.000594	0.00119	CcSEcCtD
Baclofen—Pruritus—Temozolomide—melanoma	0.000593	0.00119	CcSEcCtD
Baclofen—Convulsion—Docetaxel—melanoma	0.000592	0.00119	CcSEcCtD
Baclofen—Nausea—Bleomycin—melanoma	0.000591	0.00118	CcSEcCtD
Baclofen—Hypertension—Docetaxel—melanoma	0.00059	0.00118	CcSEcCtD
Baclofen—Vomiting—Dactinomycin—melanoma	0.00059	0.00118	CcSEcCtD
Baclofen—Rash—Dactinomycin—melanoma	0.000585	0.00117	CcSEcCtD
Baclofen—Chest pain—Docetaxel—melanoma	0.000582	0.00116	CcSEcCtD
Baclofen—Myalgia—Docetaxel—melanoma	0.000582	0.00116	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000578	0.00116	CcSEcCtD
Baclofen—Dizziness—Carmustine—melanoma	0.000574	0.00115	CcSEcCtD
Baclofen—Diarrhoea—Temozolomide—melanoma	0.000574	0.00115	CcSEcCtD
Baclofen—Dry mouth—Docetaxel—melanoma	0.000569	0.00114	CcSEcCtD
Baclofen—Confusional state—Docetaxel—melanoma	0.000562	0.00113	CcSEcCtD
Baclofen—Oedema—Docetaxel—melanoma	0.000558	0.00112	CcSEcCtD
Baclofen—Dizziness—Temozolomide—melanoma	0.000555	0.00111	CcSEcCtD
Baclofen—Infection—Docetaxel—melanoma	0.000554	0.00111	CcSEcCtD
Baclofen—Vomiting—Carmustine—melanoma	0.000552	0.0011	CcSEcCtD
Baclofen—Nausea—Dactinomycin—melanoma	0.000551	0.0011	CcSEcCtD
Baclofen—Shock—Docetaxel—melanoma	0.000549	0.0011	CcSEcCtD
Baclofen—Rash—Carmustine—melanoma	0.000547	0.0011	CcSEcCtD
Baclofen—Nervous system disorder—Docetaxel—melanoma	0.000547	0.0011	CcSEcCtD
Baclofen—Dermatitis—Carmustine—melanoma	0.000547	0.00109	CcSEcCtD
Baclofen—Tachycardia—Docetaxel—melanoma	0.000544	0.00109	CcSEcCtD
Baclofen—Headache—Carmustine—melanoma	0.000544	0.00109	CcSEcCtD
Baclofen—Skin disorder—Docetaxel—melanoma	0.000542	0.00108	CcSEcCtD
Baclofen—Vomiting—Temozolomide—melanoma	0.000533	0.00107	CcSEcCtD
Baclofen—Anorexia—Docetaxel—melanoma	0.000532	0.00106	CcSEcCtD
Baclofen—Rash—Temozolomide—melanoma	0.000529	0.00106	CcSEcCtD
Baclofen—Dermatitis—Temozolomide—melanoma	0.000528	0.00106	CcSEcCtD
Baclofen—Headache—Temozolomide—melanoma	0.000525	0.00105	CcSEcCtD
Baclofen—Hypotension—Docetaxel—melanoma	0.000521	0.00104	CcSEcCtD
Baclofen—Nausea—Carmustine—melanoma	0.000515	0.00103	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Docetaxel—melanoma	0.000508	0.00102	CcSEcCtD
Baclofen—Insomnia—Docetaxel—melanoma	0.000504	0.00101	CcSEcCtD
Baclofen—Paraesthesia—Docetaxel—melanoma	0.000501	0.001	CcSEcCtD
Baclofen—Nausea—Temozolomide—melanoma	0.000498	0.000997	CcSEcCtD
Baclofen—Dyspnoea—Docetaxel—melanoma	0.000497	0.000996	CcSEcCtD
Baclofen—Somnolence—Docetaxel—melanoma	0.000496	0.000993	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—melanoma	0.000491	0.000983	CcSEcCtD
Baclofen—Decreased appetite—Docetaxel—melanoma	0.000485	0.000971	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—melanoma	0.000482	0.000964	CcSEcCtD
Baclofen—Fatigue—Docetaxel—melanoma	0.000481	0.000963	CcSEcCtD
Baclofen—Pain—Docetaxel—melanoma	0.000477	0.000955	CcSEcCtD
Baclofen—Constipation—Docetaxel—melanoma	0.000477	0.000955	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—EDN1—melanoma	0.000476	0.00105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKR1B10—melanoma	0.000467	0.00103	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CSF2—melanoma	0.000465	0.00103	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—F2R—melanoma	0.000465	0.00103	CbGpPWpGaD
Baclofen—Feeling abnormal—Docetaxel—melanoma	0.00046	0.00092	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—melanoma	0.000456	0.000913	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CXCR2—melanoma	0.000455	0.001	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—melanoma	0.000455	0.001	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MDM2—melanoma	0.000452	0.000995	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—EDNRB—melanoma	0.00045	0.000993	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAC2—melanoma	0.000448	0.000988	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PRKCA—melanoma	0.000446	0.000983	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFC—melanoma	0.000441	0.000972	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—WNT5A—melanoma	0.000441	0.000972	CbGpPWpGaD
Baclofen—Body temperature increased—Docetaxel—melanoma	0.000441	0.000883	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—melanoma	0.000441	0.000883	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—F2RL1—melanoma	0.000434	0.000958	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EDN1—melanoma	0.000432	0.000953	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.00043	0.000948	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GAB2—melanoma	0.000425	0.000938	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GNA11—melanoma	0.000425	0.000938	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CSF2—melanoma	0.000422	0.000931	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—F2R—melanoma	0.000422	0.000931	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—RAC1—melanoma	0.000413	0.000911	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EDNRB—melanoma	0.000409	0.000902	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM3—melanoma	0.000408	0.0009	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PRKCA—melanoma	0.000405	0.000893	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—MAPK1—melanoma	0.000403	0.000888	CbGpPWpGaD
Baclofen—Asthenia—Docetaxel—melanoma	0.0004	0.000801	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCR4—melanoma	0.0004	0.000882	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAP2K2—melanoma	0.000396	0.000873	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GNAQ—melanoma	0.000395	0.000872	CbGpPWpGaD
Baclofen—Pruritus—Docetaxel—melanoma	0.000395	0.00079	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—KISS1—melanoma	0.000387	0.000854	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—F2R—melanoma	0.000387	0.000854	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GAB2—melanoma	0.000386	0.000852	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GNA11—melanoma	0.000386	0.000852	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—HRAS—melanoma	0.000385	0.000848	CbGpPWpGaD
Baclofen—Diarrhoea—Docetaxel—melanoma	0.000382	0.000764	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—RAC1—melanoma	0.000375	0.000828	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SKI—melanoma	0.000375	0.000827	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCR1—melanoma	0.000375	0.000827	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EDNRB—melanoma	0.000375	0.000827	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MC1R—melanoma	0.000369	0.000814	CbGpPWpGaD
Baclofen—Dizziness—Docetaxel—melanoma	0.000369	0.000738	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AKT3—melanoma	0.000365	0.000805	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTK2B—melanoma	0.000364	0.000802	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCR4—melanoma	0.000363	0.000801	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GNAQ—melanoma	0.000359	0.000792	CbGpPWpGaD
Baclofen—Vomiting—Docetaxel—melanoma	0.000355	0.00071	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GNA11—melanoma	0.000354	0.000781	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GAB2—melanoma	0.000354	0.000781	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM1—melanoma	0.000354	0.000781	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR7—melanoma	0.000354	0.000781	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FLT1—melanoma	0.000353	0.000777	CbGpPWpGaD
Baclofen—Rash—Docetaxel—melanoma	0.000352	0.000704	CcSEcCtD
Baclofen—Dermatitis—Docetaxel—melanoma	0.000351	0.000703	CcSEcCtD
Baclofen—Headache—Docetaxel—melanoma	0.000349	0.0007	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—melanoma	0.000349	0.00077	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SUFU—melanoma	0.000345	0.000761	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HDAC2—melanoma	0.000333	0.000734	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FOXO4—melanoma	0.000333	0.000734	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCR4—melanoma	0.000333	0.000734	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT3—melanoma	0.000331	0.000731	CbGpPWpGaD
Baclofen—Nausea—Docetaxel—melanoma	0.000331	0.000663	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GNAQ—melanoma	0.000329	0.000726	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—HRAS—melanoma	0.000323	0.000713	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RHOB—melanoma	0.000322	0.00071	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BCL2L11—melanoma	0.000322	0.00071	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—melanoma	0.000317	0.000699	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HDAC6—melanoma	0.00031	0.000682	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SYK—melanoma	0.00031	0.000682	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MAPK1—melanoma	0.000309	0.00068	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—melanoma	0.000307	0.000677	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—EDN1—melanoma	0.000307	0.000676	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NGFR—melanoma	0.000304	0.00067	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ITGAV—melanoma	0.000304	0.00067	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT3—melanoma	0.000304	0.00067	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CSF2—melanoma	0.0003	0.000661	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCR2—melanoma	0.000293	0.000647	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—melanoma	0.000293	0.000646	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAC2—melanoma	0.000289	0.000636	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCA—melanoma	0.000287	0.000633	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—WNT5A—melanoma	0.000284	0.000626	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFC—melanoma	0.000284	0.000626	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SOCS1—melanoma	0.000281	0.00062	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAP2K1—melanoma	0.000281	0.000619	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—S100B—melanoma	0.000281	0.000619	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—melanoma	0.000279	0.000615	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EDN1—melanoma	0.000278	0.000614	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CSF2—melanoma	0.000272	0.0006	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB4—melanoma	0.000268	0.000592	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—melanoma	0.000268	0.00059	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—RAC1—melanoma	0.000266	0.000587	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN2B—melanoma	0.000266	0.000586	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCA—melanoma	0.000261	0.000575	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000258	0.000568	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CD86—melanoma	0.000257	0.000567	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—melanoma	0.000257	0.000567	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EDN1—melanoma	0.000255	0.000563	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAP2K2—melanoma	0.000255	0.000562	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF1—melanoma	0.00025	0.00055	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CSF2—melanoma	0.00025	0.00055	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—F2R—melanoma	0.00025	0.00055	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HRAS—melanoma	0.000248	0.000546	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL2—melanoma	0.000246	0.000542	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—E2F1—melanoma	0.000244	0.000538	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—melanoma	0.000243	0.000536	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RAC1—melanoma	0.000242	0.000533	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	0.000242	0.000533	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFRA—melanoma	0.000242	0.000533	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDNRB—melanoma	0.000242	0.000533	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ITGB3—melanoma	0.000239	0.000527	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCA—melanoma	0.000239	0.000527	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPP1—melanoma	0.000235	0.000517	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTK2B—melanoma	0.000235	0.000517	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAP2K2—melanoma	0.000234	0.000515	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—melanoma	0.000234	0.000515	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNA11—melanoma	0.000228	0.000503	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GAB2—melanoma	0.000228	0.000503	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FLT1—melanoma	0.000227	0.000501	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—melanoma	0.000225	0.000496	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—melanoma	0.000223	0.000492	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TERT—melanoma	0.000222	0.00049	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAC1—melanoma	0.000222	0.000489	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCR4—melanoma	0.000215	0.000473	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HDAC2—melanoma	0.000215	0.000473	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FOXO4—melanoma	0.000215	0.000473	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HIF1A—melanoma	0.000213	0.000469	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNAQ—melanoma	0.000212	0.000468	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—melanoma	0.000204	0.000451	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KDR—melanoma	0.000203	0.000448	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SYK—melanoma	0.000199	0.00044	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—melanoma	0.000198	0.000436	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	0.000196	0.000433	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NGFR—melanoma	0.000196	0.000432	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ITGAV—melanoma	0.000196	0.000432	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FN1—melanoma	0.000196	0.000432	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT3—melanoma	0.000196	0.000432	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH1—melanoma	0.000192	0.000422	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CD80—melanoma	0.000188	0.000414	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KIT—melanoma	0.000187	0.000413	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—melanoma	0.000187	0.000413	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—melanoma	0.000187	0.000413	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—NRAS—melanoma	0.000187	0.000413	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGF—melanoma	0.000185	0.000408	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOCS1—melanoma	0.000181	0.0004	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAP2K1—melanoma	0.000181	0.000399	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—S100B—melanoma	0.000181	0.000399	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—melanoma	0.00018	0.000396	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—melanoma	0.000179	0.000396	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BRAF—melanoma	0.000176	0.000388	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB4—melanoma	0.000173	0.000381	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—melanoma	0.000172	0.00038	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1—melanoma	0.000172	0.000378	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN2B—melanoma	0.000171	0.000378	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK1—melanoma	0.000171	0.000376	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EGFR—melanoma	0.000171	0.000376	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CD86—melanoma	0.000166	0.000365	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAP2K1—melanoma	0.000166	0.000365	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—melanoma	0.000166	0.000365	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—melanoma	0.000165	0.000363	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDN1—melanoma	0.000164	0.000363	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—melanoma	0.000163	0.00036	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KRAS—melanoma	0.000161	0.000355	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CSF2—melanoma	0.000161	0.000354	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF1—melanoma	0.000161	0.000354	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—melanoma	0.000158	0.000349	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF2—melanoma	0.000158	0.000348	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—E2F1—melanoma	0.000157	0.000347	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—melanoma	0.000157	0.000345	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFRA—melanoma	0.000156	0.000343	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ITGB3—melanoma	0.000154	0.00034	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCA—melanoma	0.000154	0.00034	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPP1—melanoma	0.000151	0.000333	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAP2K2—melanoma	0.000151	0.000332	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—melanoma	0.00015	0.000332	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—melanoma	0.000148	0.000327	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MDM2—melanoma	0.000148	0.000325	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB2—melanoma	0.000145	0.000321	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—melanoma	0.000144	0.000317	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—melanoma	0.000144	0.000316	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TERT—melanoma	0.000143	0.000316	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAC1—melanoma	0.000143	0.000315	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—melanoma	0.000138	0.000304	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HRAS—melanoma	0.000137	0.000302	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIF1A—melanoma	0.000137	0.000302	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1B—melanoma	0.000135	0.000297	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—melanoma	0.000133	0.000294	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—melanoma	0.000132	0.000291	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—melanoma	0.000132	0.000291	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—melanoma	0.000131	0.000289	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—melanoma	0.000131	0.000289	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCND1—melanoma	0.000129	0.000283	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CTNNB1—melanoma	0.000127	0.000281	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FN1—melanoma	0.000126	0.000278	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—melanoma	0.000125	0.000275	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1A—melanoma	0.000124	0.000274	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTEN—melanoma	0.000124	0.000273	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH1—melanoma	0.000123	0.000272	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NFKB1—melanoma	0.000123	0.000272	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	0.000123	0.000271	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT1—melanoma	0.000121	0.000267	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CD80—melanoma	0.000121	0.000267	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KIT—melanoma	0.000121	0.000266	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—melanoma	0.000121	0.000266	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—melanoma	0.000121	0.000266	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—NRAS—melanoma	0.000121	0.000266	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGF—melanoma	0.000119	0.000263	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—melanoma	0.000116	0.000255	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BRAF—melanoma	0.000113	0.00025	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—melanoma	0.000112	0.000247	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—melanoma	0.000111	0.000245	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NRAS—melanoma	0.000111	0.000244	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1—melanoma	0.000111	0.000244	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK1—melanoma	0.00011	0.000243	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—melanoma	0.00011	0.000242	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAP2K1—melanoma	0.000107	0.000236	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—melanoma	0.000106	0.000234	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—melanoma	0.000106	0.000234	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—melanoma	0.000105	0.000232	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—melanoma	0.000104	0.000229	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—melanoma	0.000103	0.000227	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF2—melanoma	0.000102	0.000224	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK1—melanoma	0.000101	0.000222	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—melanoma	0.000101	0.000222	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—melanoma	9.55e-05	0.00021	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—melanoma	9.53e-05	0.00021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MDM2—melanoma	9.51e-05	0.00021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—melanoma	9.37e-05	0.000207	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—melanoma	9.25e-05	0.000204	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—melanoma	8.89e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRAS—melanoma	8.83e-05	0.000195	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—melanoma	8.75e-05	0.000193	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1B—melanoma	8.68e-05	0.000191	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—melanoma	8.59e-05	0.000189	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—melanoma	8.51e-05	0.000188	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—melanoma	8.5e-05	0.000187	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—melanoma	8.47e-05	0.000187	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—melanoma	8.45e-05	0.000186	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—melanoma	8.28e-05	0.000183	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNB1—melanoma	8.2e-05	0.000181	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HRAS—melanoma	8.1e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—melanoma	8.04e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1A—melanoma	8.01e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—melanoma	7.99e-05	0.000176	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NFKB1—melanoma	7.96e-05	0.000175	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—melanoma	7.8e-05	0.000172	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—melanoma	7.75e-05	0.000171	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—melanoma	7.22e-05	0.000159	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—melanoma	7.15e-05	0.000158	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—melanoma	7.15e-05	0.000158	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NRAS—melanoma	7.13e-05	0.000157	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK3—melanoma	6.83e-05	0.000151	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—melanoma	6.64e-05	0.000146	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK1—melanoma	6.5e-05	0.000143	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—melanoma	6.5e-05	0.000143	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—melanoma	6.14e-05	0.000135	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—melanoma	5.64e-05	0.000124	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—melanoma	5.46e-05	0.00012	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRAS—melanoma	5.22e-05	0.000115	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—melanoma	4.99e-05	0.00011	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—melanoma	4.61e-05	0.000102	CbGpPWpGaD
